Parallax Health Sciences Form 5 PARALLAX HEALTH SCIENCES / Jorn Gorlach ownership change

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0362
Estimated average burden
hours per response:	1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

Gorlach Jorn

(Last) (First) (Middle)

2154 NW EVERETT ST APT B

(Street)

PORTLAND OR 97210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PARALLAX HEALTH SCIENCES, INC. [ PRLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2019

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Amount	(A) or (D)	Price
COMMON STOCK (RESTRICTED)(2)	07/25/2019		A	1,151,443	A	$0	20,229,557	I	By Avantgarde LLC
COMMON STOCK (RESTRICTED)(2)	07/25/2019		A	229,368	A	$0	20,458,925	I	By Hamburg Investment Co

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
					(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
WARRANTS (PREFERRED SERIES B)(1)	$0.25	01/23/2019		D		15,000(1)	01/23/2017	01/23/2019	COMMON STOCK	300,000	$0	3,770,893	I	By Hamburg Investment Co
WARRANTS(2)	$0.25	07/25/2019		A	2,108,415(2)		07/25/2019	07/25/2024	COMMON STOCK	2,108,415	$0	5,879,308	I	By Avantgarde LLC
WARRANTS(2)	$0.1046	07/25/2019		A	419,998(2)		07/25/2019	07/25/2024	COMMON STOCK	419,998	$0	6,299,306	I	By Hamburg Investment Co

Explanation of Responses:

1. Expiration of warrants issued in connection with Series B Convertible Preferred Stock.

2. Issued pursuant to Settlement Agreement / Promissory Note exchange dated July 25, 2019.

	JORN GORLACH	03/04/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.